Document is current
Any future updates will be listed below
-
Authors
Li, Rui-Chi
Tang, Wei
Zhang, Hui-Lai
Wang, Xian-Huo
Sun, Rui
Wang, Nan
Xu, Tian-Yuan
Chen, Si-Yuan
Feng, Yan
Shen, Rong
Wang, Li
Cheng, Shu
Xu, Peng-Peng
Yi, Hong-Mei
Dong, Lei
Zheng, Zhong
Zhao, Wei-Li
-
Funding
Funding for this research was provided by:
National Natural Science Foundation of China (81900193)
National Natural Science Foundation of China (82130004)
National Key Research and Development Program of China (2022YFC2502600)
Chang Jiang Scholars Program, Shanghai Clinical Research Center for Cell Therapy (23J41900100)
Shanghai Municipal Education Commission Gaofeng Clinical Medicine Grant Support (20152206)
Clinical Research Plan of Shanghai Hospital Development Center (SHDC2020CR1032B)
Multicenter Clinical Research Project by Shanghai Jiao Tong University School of Medicine (DLY201601)
Multicenter Hematology-Oncology Programs Evaluation System
Collaborative Innovation Center of Systems Biomedicine
- License Information
-
More Information
Article History
Received: 18 March 2025
Accepted: 1 October 2025
First Online: 24 October 2025
Declarations
:
: The Shanghai Ruijin Hospital Institutional Review Board and Ethical Committee gave their approval to the study (2018–169). All participants gave written informed consent in accordance with the Declaration of Helsinki.
: Not applicable.
: The authors declare no competing interests.
